1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Topical 1.2.3 Oral 1.3 Market Segment by Application 1.3.1 Global Terbinafine Hydrochloride Drug Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Fingernail Infection 1.3.3 Toenail Infection 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Terbinafine Hydrochloride Drug Market Size (2017-2028) 2.1.1 Global Terbinafine Hydrochloride Drug Revenue (2017-2028) 2.1.2 Global Terbinafine Hydrochloride Drug Sales (2017-2028) 2.2 Global Terbinafine Hydrochloride Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Terbinafine Hydrochloride Drug Sales by Regions (2017-2022) 2.2.2 Global Terbinafine Hydrochloride Drug Revenue by Regions (2017-2022) 2.3 Global Terbinafine Hydrochloride Drug Market Size Forecast by Region 2.3.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Region (2023-2028) 2.3.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Region (2023-2028) 2.4 Global Top Terbinafine Hydrochloride Drug Regions (Countries) Ranking by Market Size 2.5 Terbinafine Hydrochloride Drug Market Dynamics 2.5.1 Terbinafine Hydrochloride Drug Market Trends 2.5.2 Terbinafine Hydrochloride Drug Market Drivers 2.5.3 Terbinafine Hydrochloride Drug Market Challenges 2.5.4 Terbinafine Hydrochloride Drug Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Terbinafine Hydrochloride Drug Manufacturers by Sales (2017-2022) 3.1.1 Global Terbinafine Hydrochloride Drug Sales by Manufacturers (2017-2022) 3.1.2 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Terbinafine Hydrochloride Drug Sales in 2021 3.2 Global Top Manufacturers Terbinafine Hydrochloride Drug by Revenue 3.2.1 Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (2017-2022) 3.2.2 Top Terbinafine Hydrochloride Drug Manufacturers Covered: Ranking by Revenue 3.2.3 Global Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Terbinafine Hydrochloride Drug Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2021) 3.4 Global Terbinafine Hydrochloride Drug Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Terbinafine Hydrochloride Drug Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Terbinafine Hydrochloride Drug Market 3.7 Key Manufacturers Terbinafine Hydrochloride Drug Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Terbinafine Hydrochloride Drug Market Size by Type 4.1 Global Terbinafine Hydrochloride Drug Historic Market Review by Type (2017-2022) 4.1.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2017-2022) 4.1.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2017-2022) 4.1.3 Terbinafine Hydrochloride Drug Price by Type (2017-2022) 4.2 Global Terbinafine Hydrochloride Drug Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Type (2023-2028) 4.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Type (2023-2028) 4.2.3 Terbinafine Hydrochloride Drug Price Forecast by Type (2023-2028) 5 Global Terbinafine Hydrochloride Drug Market Size by Application 5.1 Global Terbinafine Hydrochloride Drug Historic Market Review by Application (2017-2022) 5.1.1 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2017-2022) 5.1.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2017-2022) 5.1.3 Terbinafine Hydrochloride Drug Price by Application (2017-2022) 5.2 Global Terbinafine Hydrochloride Drug Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Application (2023-2028) 5.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Application (2023-2028) 5.2.3 Terbinafine Hydrochloride Drug Price Forecast by Application (2023-2028) 6 North America 6.1 North America Terbinafine Hydrochloride Drug Sales Breakdown by Company 6.1.1 North America Terbinafine Hydrochloride Drug Sales by Company (2017-2022) 6.1.2 North America Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) 6.2 North America Terbinafine Hydrochloride Drug Market Size by Type 6.2.1 North America Terbinafine Hydrochloride Drug Sales by Type (2017-2028) 6.2.2 North America Terbinafine Hydrochloride Drug Revenue by Type (2017-2028) 6.3 North America Terbinafine Hydrochloride Drug Market Size by Application 6.3.1 North America Terbinafine Hydrochloride Drug Sales by Application (2017-2028) 6.3.2 North America Terbinafine Hydrochloride Drug Revenue by Application (2017-2028) 6.4 North America Terbinafine Hydrochloride Drug Market Size by Country 6.4.1 North America Terbinafine Hydrochloride Drug Sales by Country (2017-2028) 6.4.2 North America Terbinafine Hydrochloride Drug Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Terbinafine Hydrochloride Drug Sales Breakdown by Company 7.1.1 Europe Terbinafine Hydrochloride Drug Sales by Company (2017-2022) 7.1.2 Europe Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) 7.2 Europe Terbinafine Hydrochloride Drug Market Size by Type 7.2.1 Europe Terbinafine Hydrochloride Drug Sales by Type (2017-2028) 7.2.2 Europe Terbinafine Hydrochloride Drug Revenue by Type (2017-2028) 7.3 Europe Terbinafine Hydrochloride Drug Market Size by Application 7.3.1 Europe Terbinafine Hydrochloride Drug Sales by Application (2017-2028) 7.3.2 Europe Terbinafine Hydrochloride Drug Revenue by Application (2017-2028) 7.4 Europe Terbinafine Hydrochloride Drug Market Size by Country 7.4.1 Europe Terbinafine Hydrochloride Drug Sales by Country (2017-2028) 7.4.2 Europe Terbinafine Hydrochloride Drug Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Terbinafine Hydrochloride Drug Sales Breakdown by Company 8.1.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Company (2017-2022) 8.1.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) 8.2 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Type 8.2.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Type (2017-2028) 8.2.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Type (2017-2028) 8.3 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Application 8.3.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Application (2017-2028) 8.3.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Application (2017-2028) 8.4 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Region 8.4.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Region 8.4.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Terbinafine Hydrochloride Drug Sales Breakdown by Company 9.1.1 Latin America Terbinafine Hydrochloride Drug Sales by Company (2017-2022) 9.1.2 Latin America Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) 9.2 Latin America Terbinafine Hydrochloride Drug Market Size by Type 9.2.1 Latin America Terbinafine Hydrochloride Drug Sales by Type (2017-2028) 9.2.2 Latin America Terbinafine Hydrochloride Drug Revenue by Type (2017-2028) 9.3 Latin America Terbinafine Hydrochloride Drug Market Size by Application 9.3.1 Latin America Terbinafine Hydrochloride Drug Sales by Application (2017-2028) 9.3.2 Latin America Terbinafine Hydrochloride Drug Revenue by Application (2017-2028) 9.4 Latin America Terbinafine Hydrochloride Drug Market Size by Country 9.4.1 Latin America Terbinafine Hydrochloride Drug Sales by Country (2017-2028) 9.4.2 Latin America Terbinafine Hydrochloride Drug Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales Breakdown by Company 10.1.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Company (2017-2022) 10.1.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) 10.2 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Type 10.2.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Type (2017-2028) 10.2.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Type (2017-2028) 10.3 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Application 10.3.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Application (2017-2028) 10.3.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Application (2017-2028) 10.4 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Country 10.4.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2017-2028) 10.4.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Novartis 11.1.1 Novartis Corporation Information 11.1.2 Novartis Overview 11.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Novartis Terbinafine Hydrochloride Drug Products and Services 11.1.5 Novartis Terbinafine Hydrochloride Drug SWOT Analysis 11.1.6 Novartis Recent Developments 11.2 GSK 11.2.1 GSK Corporation Information 11.2.2 GSK Overview 11.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 GSK Terbinafine Hydrochloride Drug Products and Services 11.2.5 GSK Terbinafine Hydrochloride Drug SWOT Analysis 11.2.6 GSK Recent Developments 11.3 TEVA 11.3.1 TEVA Corporation Information 11.3.2 TEVA Overview 11.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 TEVA Terbinafine Hydrochloride Drug Products and Services 11.3.5 TEVA Terbinafine Hydrochloride Drug SWOT Analysis 11.3.6 TEVA Recent Developments 11.4 Dr. Reddy's Laboratories 11.4.1 Dr. Reddy's Laboratories Corporation Information 11.4.2 Dr. Reddy's Laboratories Overview 11.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Products and Services 11.4.5 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug SWOT Analysis 11.4.6 Dr. Reddy's Laboratories Recent Developments 11.5 CIPLA LTD 11.5.1 CIPLA LTD Corporation Information 11.5.2 CIPLA LTD Overview 11.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Products and Services 11.5.5 CIPLA LTD Terbinafine Hydrochloride Drug SWOT Analysis 11.5.6 CIPLA LTD Recent Developments 11.6 TARO 11.6.1 TARO Corporation Information 11.6.2 TARO Overview 11.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 TARO Terbinafine Hydrochloride Drug Products and Services 11.6.5 TARO Terbinafine Hydrochloride Drug SWOT Analysis 11.6.6 TARO Recent Developments 11.7 InvaGen Pharmaceuticals 11.7.1 InvaGen Pharmaceuticals Corporation Information 11.7.2 InvaGen Pharmaceuticals Overview 11.7.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Products and Services 11.7.5 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug SWOT Analysis 11.7.6 InvaGen Pharmaceuticals Recent Developments 11.8 Breckenridge Pharmaceutical 11.8.1 Breckenridge Pharmaceutical Corporation Information 11.8.2 Breckenridge Pharmaceutical Overview 11.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Products and Services 11.8.5 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug SWOT Analysis 11.8.6 Breckenridge Pharmaceutical Recent Developments 11.9 Harris Pharmaceutical 11.9.1 Harris Pharmaceutical Corporation Information 11.9.2 Harris Pharmaceutical Overview 11.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Products and Services 11.9.5 Harris Pharmaceutical Terbinafine Hydrochloride Drug SWOT Analysis 11.9.6 Harris Pharmaceutical Recent Developments 11.10 Glenmark 11.10.1 Glenmark Corporation Information 11.10.2 Glenmark Overview 11.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Glenmark Terbinafine Hydrochloride Drug Products and Services 11.10.5 Glenmark Terbinafine Hydrochloride Drug SWOT Analysis 11.10.6 Glenmark Recent Developments 11.11 Orchid Healthcare 11.11.1 Orchid Healthcare Corporation Information 11.11.2 Orchid Healthcare Overview 11.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Products and Services 11.11.5 Orchid Healthcare Recent Developments 11.12 APOTEX 11.12.1 APOTEX Corporation Information 11.12.2 APOTEX Overview 11.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 APOTEX Terbinafine Hydrochloride Drug Products and Services 11.12.5 APOTEX Recent Developments 11.13 Jilin Wantong Group 11.13.1 Jilin Wantong Group Corporation Information 11.13.2 Jilin Wantong Group Overview 11.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Products and Services 11.13.5 Jilin Wantong Group Recent Developments 11.14 Cussess 11.14.1 Cussess Corporation Information 11.14.2 Cussess Overview 11.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 Cussess Terbinafine Hydrochloride Drug Products and Services 11.14.5 Cussess Recent Developments 11.15 Hubei Hengan Fulin Pharm 11.15.1 Hubei Hengan Fulin Pharm Corporation Information 11.15.2 Hubei Hengan Fulin Pharm Overview 11.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Products and Services 11.15.5 Hubei Hengan Fulin Pharm Recent Developments 11.16 Xiuzheng Pharmaceutical 11.16.1 Xiuzheng Pharmaceutical Corporation Information 11.16.2 Xiuzheng Pharmaceutical Overview 11.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Products and Services 11.16.5 Xiuzheng Pharmaceutical Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Terbinafine Hydrochloride Drug Value Chain Analysis 12.2 Terbinafine Hydrochloride Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Terbinafine Hydrochloride Drug Production Mode & Process 12.4 Terbinafine Hydrochloride Drug Sales and Marketing 12.4.1 Terbinafine Hydrochloride Drug Sales Channels 12.4.2 Terbinafine Hydrochloride Drug Distributors 12.5 Terbinafine Hydrochloride Drug Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Topical Table 3. Major Manufacturers of Oral Table 4. Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Terbinafine Hydrochloride Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Terbinafine Hydrochloride Drug Sales by Region (2017-2022) & (K Units) Table 7. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2017-2022) Table 8. Global Terbinafine Hydrochloride Drug Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2017-2022) Table 10. Global Terbinafine Hydrochloride Drug Sales Forecast by Region (2023-2028) & (K Units) Table 11. Global Terbinafine Hydrochloride Drug Sales Market Share Forecast by Region (2023-2028) Table 12. Global Terbinafine Hydrochloride Drug Revenue Forecast by Region (2023-2028) & (US$ Million) Table 13. Global Terbinafine Hydrochloride Drug Revenue Market Share Forecast by Region (2023-2028) Table 14. Top Terbinafine Hydrochloride Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 15. Terbinafine Hydrochloride Drug Market Trends Table 16. Terbinafine Hydrochloride Drug Market Drivers Table 17. Terbinafine Hydrochloride Drug Market Challenges Table 18. Terbinafine Hydrochloride Drug Market Restraints Table 19. Global Terbinafine Hydrochloride Drug Sales by Manufacturers (2017-2022) & (K Units) Table 20. Global Terbinafine Hydrochloride Drug Sales Share by Manufacturers (2017-2022) Table 21. Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (2017-2022) & (US$ Million) Table 22. Ranking of Global Top Terbinafine Hydrochloride Drug Manufacturers by Revenue (US$ Million) in 2021 Table 23. Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2017-2022) Table 24. Global Terbinafine Hydrochloride Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2021) Table 26. Key Manufacturers Terbinafine Hydrochloride Drug Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 27. Key Manufacturers Terbinafine Hydrochloride Drug Plants/Factories Distribution Table 28. Key Manufacturers Terbinafine Hydrochloride Drug Area Served Table 29. Date of Key Manufacturers Enter into Terbinafine Hydrochloride Drug Market Table 30. Key Manufacturers Terbinafine Hydrochloride Drug Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2017-2022) Table 33. Global Terbinafine Hydrochloride Drug Sales Share by Type (2017-2022) Table 34. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) Market Share by Type (2017-2022) Table 35. Global Terbinafine Hydrochloride Drug Price (K Units) by Type (2017-2022) Table 36. Global Terbinafine Hydrochloride Drug Sales (K Units) by Type (2023-2028) Table 37. Global Terbinafine Hydrochloride Drug Sales Share by Type (2023-2028) Table 38. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) Market Share by Type (2023-2028) Table 39. Global Terbinafine Hydrochloride Drug Revenue Share by Type (2023-2028) Table 40. Global Terbinafine Hydrochloride Drug Price (K Units) by Type (2023-2028) Table 41. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2017-2022) Table 42. Global Terbinafine Hydrochloride Drug Sales Share by Application (2017-2022) Table 43. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) Market Share by Application (2017-2022) Table 44. Global Terbinafine Hydrochloride Drug Price (K Units) by Application (2017-2022) Table 45. Global Terbinafine Hydrochloride Drug Sales (K Units) by Application (2023-2028) Table 46. Global Terbinafine Hydrochloride Drug Sales Share by Application (2023-2028) Table 47. Global Terbinafine Hydrochloride Drug Revenue (US$ Million) Market Share by Application (2023-2028) Table 48. Global Terbinafine Hydrochloride Drug Revenue Share by Application (2023-2028) Table 49. Global Terbinafine Hydrochloride Drug Price (K Units) by Application (2023-2028) Table 50. North America Terbinafine Hydrochloride Drug Sales by Company (2017-2022) & (K Units) Table 51. North America Terbinafine Hydrochloride Drug Sales Market Share by Company (2017-2022) Table 52. North America Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) & (US$ Million) Table 53. North America Terbinafine Hydrochloride Drug Revenue Market Share by Company (2017-2022) Table 54. North America Terbinafine Hydrochloride Drug Sales by Type (2017-2022) & (K Units) Table 55. North America Terbinafine Hydrochloride Drug Sales by Type (2023-2028) & (K Units) Table 56. North America Terbinafine Hydrochloride Drug Revenue by Type (2017-2022) & (US$ Million) Table 57. North America Terbinafine Hydrochloride Drug Revenue by Type (2023-2028) & (US$ Million) Table 58. North America Terbinafine Hydrochloride Drug Sales by Application (2017-2022) & (K Units) Table 59. North America Terbinafine Hydrochloride Drug Sales by Application (2023-2028) & (K Units) Table 60. North America Terbinafine Hydrochloride Drug Revenue by Application (2017-2022) & (US$ Million) Table 61. North America Terbinafine Hydrochloride Drug Revenue by Application (2023-2028) & (US$ Million) Table 62. North America Terbinafine Hydrochloride Drug Sales by Country (2017-2022) & (K Units) Table 63. North America Terbinafine Hydrochloride Drug Sales by Country (2023-2028) & (K Units) Table 64. North America Terbinafine Hydrochloride Drug Revenue by Country (2017-2022) & (US$ Million) Table 65. North America Terbinafine Hydrochloride Drug Revenue by Country (2023-2028) & (US$ Million) Table 66. Europe Terbinafine Hydrochloride Drug Sales by Company (2017-2022) & (K Units) Table 67. Europe Terbinafine Hydrochloride Drug Sales Market Share by Company (2017-2022) Table 68. Europe Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) & (US$ Million) Table 69. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Company (2017-2022) Table 70. Europe Terbinafine Hydrochloride Drug Sales by Type (2017-2022) & (K Units) Table 71. Europe Terbinafine Hydrochloride Drug Sales by Type (2023-2028) & (K Units) Table 72. Europe Terbinafine Hydrochloride Drug Revenue by Type (2017-2022) & (US$ Million) Table 73. Europe Terbinafine Hydrochloride Drug Revenue by Type (2023-2028) & (US$ Million) Table 74. Europe Terbinafine Hydrochloride Drug Sales by Application (2017-2022) & (K Units) Table 75. Europe Terbinafine Hydrochloride Drug Sales by Application (2023-2028) & (K Units) Table 76. Europe Terbinafine Hydrochloride Drug Revenue by Application (2017-2022) & (US$ Million) Table 77. Europe Terbinafine Hydrochloride Drug Revenue by Application (2023-2028) & (US$ Million) Table 78. Europe Terbinafine Hydrochloride Drug Sales by Country (2017-2022) & (K Units) Table 79. Europe Terbinafine Hydrochloride Drug Sales by Country (2023-2028) & (K Units) Table 80. Europe Terbinafine Hydrochloride Drug Revenue by Country (2017-2022) & (US$ Million) Table 81. Europe Terbinafine Hydrochloride Drug Revenue by Country (2023-2028) & (US$ Million) Table 82. Asia Pacific Terbinafine Hydrochloride Drug Sales by Company (2017-2022) & (K Units) Table 83. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Company (2017-2022) Table 84. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) & (US$ Million) Table 85. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Company (2017-2022) Table 86. Asia Pacific Terbinafine Hydrochloride Drug Sales by Type (2017-2022) & (K Units) Table 87. Asia Pacific Terbinafine Hydrochloride Drug Sales by Type (2023-2028) & (K Units) Table 88. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Type (2017-2022) & (US$ Million) Table 89. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Type (2023-2028) & (US$ Million) Table 90. Asia Pacific Terbinafine Hydrochloride Drug Sales by Application (2017-2022) & (K Units) Table 91. Asia Pacific Terbinafine Hydrochloride Drug Sales by Application (2023-2028) & (K Units) Table 92. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Application (2017-2022) & (US$ Million) Table 93. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Application (2023-2028) & (US$ Million) Table 94. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2017-2022) & (K Units) Table 95. Asia Pacific Terbinafine Hydrochloride Drug Sales by Region (2023-2028) & (K Units) Table 96. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2017-2022) & (US$ Million) Table 97. Asia Pacific Terbinafine Hydrochloride Drug Revenue by Region (2023-2028) & (US$ Million) Table 98. Latin America Terbinafine Hydrochloride Drug Sales by Company (2017-2022) & (K Units) Table 99. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Company (2017-2022) Table 100. Latin America Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) & (US$ Million) Table 101. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Company (2017-2022) Table 102. Latin America Terbinafine Hydrochloride Drug Sales by Type (2017-2022) & (K Units) Table 103. Latin America Terbinafine Hydrochloride Drug Sales by Type (2023-2028) & (K Units) Table 104. Latin America Terbinafine Hydrochloride Drug Revenue by Type (2017-2022) & (US$ Million) Table 105. Latin America Terbinafine Hydrochloride Drug Revenue by Type (2023-2028) & (US$ Million) Table 106. Latin America Terbinafine Hydrochloride Drug Sales by Application (2017-2022) & (K Units) Table 107. Latin America Terbinafine Hydrochloride Drug Sales by Application (2023-2028) & (K Units) Table 108. Latin America Terbinafine Hydrochloride Drug Revenue by Application (2017-2022) & (US$ Million) Table 109. Latin America Terbinafine Hydrochloride Drug Revenue by Application (2023-2028) & (US$ Million) Table 110. Latin America Terbinafine Hydrochloride Drug Sales by Country (2017-2022) & (K Units) Table 111. Latin America Terbinafine Hydrochloride Drug Sales by Country (2023-2028) & (K Units) Table 112. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2017-2022) & (US$ Million) Table 113. Latin America Terbinafine Hydrochloride Drug Revenue by Country (2023-2028) & (US$ Million) Table 114. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Company (2017-2022) & (K Units) Table 115. Middle East and Africa Terbinafine Hydrochloride Drug Sales Market Share by Company (2017-2022) Table 116. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Company (2017-2022) & (US$ Million) Table 117. Middle East and Africa Terbinafine Hydrochloride Drug Revenue Market Share by Company (2017-2022) Table 118. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Type (2017-2022) & (K Units) Table 119. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Type (2023-2028) & (K Units) Table 120. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Type (2017-2022) & (US$ Million) Table 121. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Type (2023-2028) & (US$ Million) Table 122. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Application (2017-2022) & (K Units) Table 123. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Application (2023-2028) & (K Units) Table 124. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Application (2017-2022) & (US$ Million) Table 125. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Application (2023-2028) & (US$ Million) Table 126. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2017-2022) & (K Units) Table 127. Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2023-2028) & (K Units) Table 128. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2017-2022) & (US$ Million) Table 129. Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2023-2028) & (US$ Million) Table 130. Novartis Corporation Information Table 131. Novartis Description and Overview Table 132. Novartis Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 133. Novartis Terbinafine Hydrochloride Drug Product and Services Table 134. Novartis Terbinafine Hydrochloride Drug SWOT Analysis Table 135. Novartis Recent Developments Table 136. GSK Corporation Information Table 137. GSK Description and Overview Table 138. GSK Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 139. GSK Terbinafine Hydrochloride Drug Product and Services Table 140. GSK Terbinafine Hydrochloride Drug SWOT Analysis Table 141. GSK Recent Developments Table 142. TEVA Corporation Information Table 143. TEVA Description and Overview Table 144. TEVA Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 145. TEVA Terbinafine Hydrochloride Drug Product and Services Table 146. TEVA Terbinafine Hydrochloride Drug SWOT Analysis Table 147. TEVA Recent Developments Table 148. Dr. Reddy's Laboratories Corporation Information Table 149. Dr. Reddy's Laboratories Description and Overview Table 150. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 151. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product and Services Table 152. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug SWOT Analysis Table 153. Dr. Reddy's Laboratories Recent Developments Table 154. CIPLA LTD Corporation Information Table 155. CIPLA LTD Description and Overview Table 156. CIPLA LTD Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 157. CIPLA LTD Terbinafine Hydrochloride Drug Product and Services Table 158. CIPLA LTD Terbinafine Hydrochloride Drug SWOT Analysis Table 159. CIPLA LTD Recent Developments Table 160. TARO Corporation Information Table 161. TARO Description and Overview Table 162. TARO Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 163. TARO Terbinafine Hydrochloride Drug Product and Services Table 164. TARO Terbinafine Hydrochloride Drug SWOT Analysis Table 165. TARO Recent Developments Table 166. InvaGen Pharmaceuticals Corporation Information Table 167. InvaGen Pharmaceuticals Description and Overview Table 168. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 169. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product and Services Table 170. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug SWOT Analysis Table 171. InvaGen Pharmaceuticals Recent Developments Table 172. Breckenridge Pharmaceutical Corporation Information Table 173. Breckenridge Pharmaceutical Description and Overview Table 174. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 175. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product and Services Table 176. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug SWOT Analysis Table 177. Breckenridge Pharmaceutical Recent Developments Table 178. Harris Pharmaceutical Corporation Information Table 179. Harris Pharmaceutical Description and Overview Table 180. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 181. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product and Services Table 182. Harris Pharmaceutical Terbinafine Hydrochloride Drug SWOT Analysis Table 183. Harris Pharmaceutical Recent Developments Table 184. Glenmark Corporation Information Table 185. Glenmark Description and Overview Table 186. Glenmark Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 187. Glenmark Terbinafine Hydrochloride Drug Product and Services Table 188. Glenmark Terbinafine Hydrochloride Drug SWOT Analysis Table 189. Glenmark Recent Developments Table 190. Orchid Healthcare Corporation Information Table 191. Orchid Healthcare Description and Overview Table 192. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 193. Orchid Healthcare Terbinafine Hydrochloride Drug Product and Services Table 194. Orchid Healthcare Recent Developments Table 195. APOTEX Corporation Information Table 196. APOTEX Description and Overview Table 197. APOTEX Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 198. APOTEX Terbinafine Hydrochloride Drug Product and Services Table 199. APOTEX Recent Developments Table 200. Jilin Wantong Group Corporation Information Table 201. Jilin Wantong Group Description and Overview Table 202. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 203. Jilin Wantong Group Terbinafine Hydrochloride Drug Product and Services Table 204. Jilin Wantong Group Recent Developments Table 205. Cussess Corporation Information Table 206. Cussess Description and Overview Table 207. Cussess Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 208. Cussess Terbinafine Hydrochloride Drug Product and Services Table 209. Cussess Recent Developments Table 210. Hubei Hengan Fulin Pharm Corporation Information Table 211. Hubei Hengan Fulin Pharm Description and Overview Table 212. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 213. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product and Services Table 214. Hubei Hengan Fulin Pharm Recent Developments Table 215. Xiuzheng Pharmaceutical Corporation Information Table 216. Xiuzheng Pharmaceutical Description and Overview Table 217. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 218. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product and Services Table 219. Xiuzheng Pharmaceutical Recent Developments Table 220. Key Raw Materials Lists Table 221. Raw Materials Key Suppliers Lists Table 222. Terbinafine Hydrochloride Drug Distributors List Table 223. Terbinafine Hydrochloride Drug Customers List Table 224. Research Programs/Design for This Report Table 225. Key Data Information from Secondary Sources Table 226. Key Data Information from Primary Sources List of Figures Figure 1. Terbinafine Hydrochloride Drug Product Picture Figure 2. Global Terbinafine Hydrochloride Drug Sales Market Share by Type in 2021 & 2028 Figure 3. Topical Product Picture Figure 4. Oral Product Picture Figure 5. Global Terbinafine Hydrochloride Drug Sales Market Share by Application in 2021 & 2028 Figure 6. Fingernail Infection Use Case Figure 7. Toenail Infection Use Case Figure 8. Others Use Case Figure 9. Terbinafine Hydrochloride Drug Report Years Considered Figure 10. Global Terbinafine Hydrochloride Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Terbinafine Hydrochloride Drug Market Size 2017-2028 (US$ Million) Figure 12. Global Terbinafine Hydrochloride Drug Sales (2017-2022) & (K Units) Figure 13. Global Terbinafine Hydrochloride Drug Market Size Market Share by Region: 2021 VS 2028 Figure 14. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2017-2022) Figure 15. Global Terbinafine Hydrochloride Drug Sales Market Share by Region in 2021 Figure 16. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region in 2017 VS 2021 Figure 17. Global Terbinafine Hydrochloride Drug Sales Share by Manufacturers in 2021 Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Terbinafine Hydrochloride Drug Sales in 2021 Figure 19. Terbinafine Hydrochloride Drug Revenue Share by Manufacturers in 2021 Figure 20. Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 21. Global Terbinafine Hydrochloride Drug Revenue Share by Type (2017-2022) Figure 22. Global Terbinafine Hydrochloride Drug Revenue Growth Rate by Type in 2017 & 2021 Figure 23. Global Terbinafine Hydrochloride Drug Revenue Share by Application (2017-2022) Figure 24. Global Terbinafine Hydrochloride Drug Revenue Growth Rate by Application in 2017 & 2021 Figure 25. North America Terbinafine Hydrochloride Drug Sales Market Share by Type (2017-2028) Figure 26. North America Terbinafine Hydrochloride Drug Revenue Market Share by Type (2017-2028) Figure 27. North America Terbinafine Hydrochloride Drug Sales Market Share by Application (2017-2028) Figure 28. North America Terbinafine Hydrochloride Drug Revenue Market Share by Application (2017-2028) Figure 29. North America Terbinafine Hydrochloride Drug Sales Share by Country (2017-2028) Figure 30. North America Terbinafine Hydrochloride Drug Revenue Share by Country (2017-2028) Figure 31. U.S. Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 32. Canada Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 33. Europe Terbinafine Hydrochloride Drug Sales Market Share by Type (2017-2028) Figure 34. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Type (2017-2028) Figure 35. Europe Terbinafine Hydrochloride Drug Sales Market Share by Application (2017-2028) Figure 36. Europe Terbinafine Hydrochloride Drug Revenue Market Share by Application (2017-2028) Figure 37. Europe Terbinafine Hydrochloride Drug Sales Share by Country (2017-2028) Figure 38. Europe Terbinafine Hydrochloride Drug Revenue Share by Country (2017-2028) Figure 39. Germany Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 40. France Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 41. U.K. Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 42. Italy Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 43. Russia Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 44. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Type (2017-2028) Figure 45. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Type (2017-2028) Figure 46. Asia Pacific Terbinafine Hydrochloride Drug Sales Market Share by Application (2017-2028) Figure 47. Asia Pacific Terbinafine Hydrochloride Drug Revenue Market Share by Application (2017-2028) Figure 48. Asia Pacific Terbinafine Hydrochloride Drug Sales Share by Region (2017-2028) Figure 49. Asia Pacific Terbinafine Hydrochloride Drug Revenue Share by Region (2017-2028) Figure 50. China Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 51. Japan Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 52. South Korea Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 53. India Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 54. Australia Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 55. Taiwan Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 56. Indonesia Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 57. Thailand Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 58. Malaysia Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 59. Philippines Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 60. Vietnam Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 61. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Type (2017-2028) Figure 62. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Type (2017-2028) Figure 63. Latin America Terbinafine Hydrochloride Drug Sales Market Share by Application (2017-2028) Figure 64. Latin America Terbinafine Hydrochloride Drug Revenue Market Share by Application (2017-2028) Figure 65. Latin America Terbinafine Hydrochloride Drug Sales Share by Country (2017-2028) Figure 66. Latin America Terbinafine Hydrochloride Drug Revenue Share by Country (2017-2028) Figure 67. Mexico Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 68. Brazil Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 69. Argentina Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 70. Middle East and Africa Terbinafine Hydrochloride Drug Sales Market Share by Type (2017-2028) Figure 71. Middle East and Africa Terbinafine Hydrochloride Drug Revenue Market Share by Type (2017-2028) Figure 72. Middle East and Africa Terbinafine Hydrochloride Drug Sales Market Share by Application (2017-2028) Figure 73. Middle East and Africa Terbinafine Hydrochloride Drug Revenue Market Share by Application (2017-2028) Figure 74. Middle East and Africa Terbinafine Hydrochloride Drug Sales Share by Country (2017-2028) Figure 75. Middle East and Africa Terbinafine Hydrochloride Drug Revenue Share by Country (2017-2028) Figure 76. Turkey Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 77. Saudi Arabia Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 78. UAE Terbinafine Hydrochloride Drug Revenue (2017-2028) & (US$ Million) Figure 79. Terbinafine Hydrochloride Drug Value Chain Figure 80. Terbinafine Hydrochloride Drug Production Process Figure 81. Channels of Distribution Figure 82. Distributors Profiles Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Novartis GSK TEVA Dr. Reddy's Laboratories CIPLA LTD TARO InvaGen Pharmaceuticals Breckenridge Pharmaceutical Harris Pharmaceutical Glenmark Orchid Healthcare APOTEX Jilin Wantong Group Cussess Hubei Hengan Fulin Pharm Xiuzheng Pharmaceutical